NCT06621212
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Clinical trial condition
Myeloid Malignancy
Explore clinical trials studying Myeloid Malignancy. Study availability and eligibility vary by location and protocol.
17 public trials
14 recruiting studies
Myeloid Malignancy trial results
NCT06378437
- Conditions
- Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
- Locations
-
- The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
- China-Japan Friendship Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
- The First Hospital of Hebei Medical Universtiy Shijiazhuang, Hebei, China
NCT07011186
- Conditions
- Myeloid Malignancy
- Locations
-
- The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
- Beijing Chaoyang Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Beijing Tsinghua Changgung Hospital Beijing, Beijing Municipality, China
NCT05841771
- Conditions
- Hypomethylating Agent, Myeloid Malignancy, Venetoclax
- Locations
-
- Shanghai Jiao Tong University School of Medicine Affilated Shanghai General Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients
NCT06090513
- Conditions
- Advanced Cancer, Myeloid Malignancy, Solid Tumor, Adult
- Locations
-
- Carolina Blood and Cancer Care Associates Rock Hill, South Carolina, United States
Completed
APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies
NCT04214860
- Conditions
- Myeloid Malignancy
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- H. Lee Moffitt CC Tampa, Florida, United States
- Northwestern Medicine Chicago, Illinois, United States
- University of Chicago Medicine Chicago, Illinois, United States
Active, Not Recruiting
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
NCT05455294
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +12 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States